Long-term longitudinal evaluation of the sele s128r polymorphism and serum E-selectin levels in autosomal dominant polycystic kidney disease
4 affiliations
- 1Department of Nephrology, Bağcılar Training and Research Hospital, University of Health Sciences, Istanbul, Turkey
- 2Department of Internal Medicine, Bağcılar Training and Research Hospital, University of Health Sciences, Istanbul, Turkey
- 3Department of Radiology, Bağcılar Training and Research Hospital, University of Health Sciences, Istanbul, Turkey
- 4Department of Genetics and Medical Biology, Medical School of Harran University, Sanlıurfa, Turkey
Abstract
Objective: Autosomal dominant polycystic kidney disease (ADPKD) is characterized by progressive cyst formation and kidney enlargement, ultimately leading to chronic kidney disease. Although E-selectin has been implicated in endothelial activation and inflammation, the long-term associations of serum E-selectin levels and the SELE S128R (rs5361) polymorphism with ADPKD progression remain unclear. The aim of this study was to evaluate the associations of baseline serum E-selectin levels and the SELE S128R polymorphism with long-term structural and functional disease progression in patients with ADPKD.
Methods: In this longitudinal study, 20 patients with ADPKD who had complete 10-year follow-up data from an initial cohort of 76 patients were included. Clinical, biochemical, and magnetic resonance imaging (MRI) data obtained at baseline and after approximately 10 years were compared. Total kidney volume (TKV), height-adjusted total kidney volume (htTKV), and dominant renal cyst volume were evaluated using MRI. The Mayo Imaging Classification was used for prognostic risk assessment when baseline classification was available. Serum E-selectin levels were measured using an enzyme-linked immunosorbent assay (ELISA) method, and the SELE S128R gene polymorphism was analyzed using the polymerase chain reaction–restriction fragment length polymorphism (PCR-RFLP) method. Patients were grouped according to AA and AC + CC genotypes.
Results: During the approximately 10-year follow-up, TKV and htTKV significantly increased (p = 0.001 for both), whereas renal function worsened, as demonstrated by a significant increase in serum creatinine (p = 0.022) and decline in eGFR (p = 0.002). Left dominant cyst volume also increased significantly (p = 0.013). Serum E-selectin levels did not change significantly over time. No significant differences were observed between the AA and AC + CC genotype groups in terms of imaging or biochemical parameters at baseline or at follow-up. Within the AA genotype group, TKV and htTKV showed significant increases over time (p = 0.008 for both), and nominally significant changes were also observed in serum creatinine (p = 0.023), eGFR (p = 0.009), and parathyroid hormone (PTH) levels (p = 0.021). However, these within-group changes were not significantly different from those observed in the AC + CC group.
Conclusion: Neither the SELE S128R polymorphism nor baseline serum E-selectin levels was significantly associated with changes in TKV, htTKV, dominant cyst volume, or eGFR.
Related
- Evaluation of γδ T cells in autosomal dominant polycystic kidney disease
- Pregnancy and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney Disease
- Case Report: transient migratory pulmonary nodules with bronchial artery malformations in an autosomal dominant polycystic kidney disease patient: a case of recurrent hemoptysis.
- Beyond Hematuria: An Unexpected Diagnosis of Autosomal Dominant Polycystic Kidney Disease in a Young Adult Without a Family History.
- The population frequency of predicted pathogenic variants in the genes associated with Autosomal Dominant Polycystic Liver Disease (ADPLD) and kidney cysts
BibTeX
@article{esen2026longterm,
title = {{Long-term longitudinal evaluation of the sele s128r polymorphism and serum E-selectin levels in autosomal dominant polycystic kidney disease}},
author = {Bennur Esen and Ahmet Engin Atay and Tarık Sayın and Ferdi Karagöz and Halit Akbas},
journal = {BMC Nephrology},
year = {2026},
month = sep,
doi = {10.1186/s12882-026-05349-3},
url = {https://doi.org/10.1186/s12882-026-05349-3},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Long-term longitudinal evaluation of the sele s128r polymorphism and serum E-selectin levels in autosomal dominant polycystic kidney disease
AU - Bennur Esen
AU - Ahmet Engin Atay
AU - Tarık Sayın
AU - Ferdi Karagöz
AU - Halit Akbas
PY - 2026
DA - 2026/09/11
JO - BMC Nephrology
DO - 10.1186/s12882-026-05349-3
UR - https://doi.org/10.1186/s12882-026-05349-3
AB - Objective: Autosomal dominant polycystic kidney disease (ADPKD) is characterized by progressive cyst formation and kidney enlargement, ultimately leading to chronic kidney disease. Although E-selectin has been implicated in endothelial activation and inflammation, the long-term associations of serum E-selectin levels and the SELE S128R (rs5361) polymorphism with ADPKD progression remain unclear. The aim of this study was to evaluate the associations of baseline serum E-selectin levels and the SELE S128R polymorphism with long-term structural and functional disease progression in patients with ADPKD. Methods: In this longitudinal study, 20 patients with ADPKD who had complete 10-year follow-up data from an initial cohort of 76 patients were included. Clinical, biochemical, and magnetic resonance imaging (MRI) data obtained at baseline and after approximately 10 years were compared. Total kidney volume (TKV), height-adjusted total kidney volume (htTKV), and dominant renal cyst volume were evaluated using MRI. The Mayo Imaging Classification was used for prognostic risk assessment when baseline classification was available. Serum E-selectin levels were measured using an enzyme-linked immunosorbent assay (ELISA) method, and the SELE S128R gene polymorphism was analyzed using the polymerase chain reaction–restriction fragment length polymorphism (PCR-RFLP) method. Patients were grouped according to AA and AC + CC genotypes. Results: During the approximately 10-year follow-up, TKV and htTKV significantly increased (p = 0.001 for both), whereas renal function worsened, as demonstrated by a significant increase in serum creatinine (p = 0.022) and decline in eGFR (p = 0.002). Left dominant cyst volume also increased significantly (p = 0.013). Serum E-selectin levels did not change significantly over time. No significant differences were observed between the AA and AC + CC genotype groups in terms of imaging or biochemical parameters at baseline or at follow-up. Within the AA genotype group, TKV and htTKV showed significant increases over time (p = 0.008 for both), and nominally significant changes were also observed in serum creatinine (p = 0.023), eGFR (p = 0.009), and parathyroid hormone (PTH) levels (p = 0.021). However, these within-group changes were not significantly different from those observed in the AC + CC group. Conclusion: Neither the SELE S128R polymorphism nor baseline serum E-selectin levels was significantly associated with changes in TKV, htTKV, dominant cyst volume, or eGFR.
SN - 1471-2369
ER -